Calamos Advisors
APYX icon

Calamos Advisors’s Apyx Medical APYX Stock Holding History

Calamos Advisors’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-138,699
Closed -$1.78M – 1159
2021
Q4 		$1.78M Sell
138,699
-3,876
-3% -$54.2K 0.01% 919
2021
Q3 		$1.97M Buy
142,575
+14,794
+12% +$156K 0.01% 783
2021
Q2 		$1.32M Buy
127,781
+18,409
+17% +$182K 0.01% 775
2021
Q1 		$1.06M Buy
109,372
+35,056
+47% +$351K 0.01% 762
2020
Q4 		$535K Buy
+74,316
New +$493K ﹤0.01% 711
2020
Q1 		– Sell
-137,671
Closed -$1.16M – 707
2019
Q4 		$1.16M Buy
+137,671
New +$995K 0.01% 657

Other funds holding APYX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CAC
Cowen and Company New York $2.9B AUM 105.26% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $9.23B AUM 27.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return